Dexalgin Inject solution for injection 50mg/2ml, 5 pcs — Made in Germany — Free Delivery

Indications for use

For oral administration: pain syndrome of mild to moderate intensity in the following diseases and conditions:

• acute and chronic inflammatory diseases of the musculoskeletal system (rheumatoid arthritis, spondyloarthritis, arthrosis, osteochondrosis);
• dysmenorrhea;
• toothache.

For parenteral administration:

• relief of pain syndrome of various origins (including postoperative pain, pain in bone metastases, post-traumatic pain, pain in renal colic, algomenorrhea, sciatica, sciatica, neuralgia, toothache);
• symptomatic treatment of acute and chronic inflammatory, inflammatory-degenerative and metabolic diseases of the musculoskeletal system (including rheumatoid arthritis, osteoarthritis, spondyloarthritis: ankylosing spondylitis, reactive arthritis, psoriatic arthritis).

Dosage regimen

For oral administration, the average single dose is 12.5 mg - 1-6 times / day every 4-6 hours as needed, or 25 mg 1-3 times / day every 8 hours. The maximum daily dose is 75 mg. Duration of use - no more than 3-5 days.

For parenteral administration (IM or IV), the recommended adult dose is 50 mg every 8-12 hours.

For patients with impaired liver or kidney function, elderly patients, the initial dose is not more than 50 mg / day.

Side effects

From the digestive system:

• heartburn, abdominal pain;
• rarely - erosive and ulcerative lesions of the gastrointestinal tract.
• From the nervous system:
• headaches, dizziness, nervousness, sleep disturbance, paresthesia.

On the part of the cardiovascular system:

• palpitations, increased blood pressure.

Allergic reactions:

• skin rash, bronchospasm.

Others:

• chills, swelling of the limbs, photosensitivity;
• rarely - a change in the picture of peripheral blood, renal dysfunction.

Contraindications for use

Peptic ulcer and duodenal ulcer, gastrointestinal bleeding, active bleeding of various origins, increased bleeding, anticoagulant therapy, Crohn's disease, ulcerative colitis, bronchial asthma (including history), severe heart failure, severe renal failure, severe liver failure, pregnancy, lactation, children under 18 years of age, hypersensitivity to dexketoprofen or other NSAIDs.

Application during pregnancy and lactation

Use during pregnancy and lactation is contraindicated.

Application for violations of liver function

Contraindicated in liver failure. For patients with impaired liver function, the initial dose is no more than 50 mg / day.

Application for impaired renal function

Contraindicated in renal failure. For patients with impaired renal function, the initial dose is no more than 50 mg / day.

Use in elderly patients

Care should be taken when prescribing the preparation to elderly patients. For the elderly, the initial dose is no more than 50 mg / day.

Application in children

The preparation is contraindicated for use in children and adolescents under the age of 18 years.

Special instructions

Care should be taken when prescribing the preparation to elderly patients, patients with allergic reactions, systemic diseases of the connective tissue and patients with impaired hematopoiesis.

Patients should be informed that in case of side effects, as well as in the absence of a clinical effect within 3-5 days of treatment, it is necessary to inform the attending physician about it.

Special care is required with the simultaneous use of dexketoprofen with phenytoin, sulfonamides and preparations that reduce blood clotting.

Influence on the ability to drive vehicles and mechanisms

Since dexketoprofen can cause a decrease in the ability to concentrate, it should be used with caution in patients engaged in potentially hazardous activities that require increased attention and speed of psychomotor reactions.

Preparation interactions

With the simultaneous use of dexketoprofen with other NSAIDs, the risk of side effects may increase.

With simultaneous use with lithium preparations, it is possible to increase the concentration of the latter in the blood plasma.

Use dexketoprofen with caution less than 24 hours before the start of use or after the end of methotrexate therapy. the concentration of the latter in blood plasma (and therefore toxicity) may increase.

Some cases of bleeding with the simultaneous use of NSAIDs and anticoagulants are described.